These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8141119)

  • 21. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
    White GC; Shapiro AD; Kurczynski EM; Kim HC; Bergman GE
    Thromb Haemost; 1995 May; 73(5):779-84. PubMed ID: 7482403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Remission of a non-haemophilic patient with acquired factor VIII inhibitor treated with infusion of factor VIII and corticosteroid].
    Honda J; Egami K; Osabe S; Natori H; Nakamura E; Tanaka K; Naitou K; Kaji M
    Rinsho Ketsueki; 1989 Apr; 30(4):520-4. PubMed ID: 2504978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of factor VIII inhibitors in non-hemophilic patients.
    Green D
    Prog Clin Biol Res; 1984; 150():337-52. PubMed ID: 6431438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of factor VIII: detection and treatment.
    Brettler DB
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An acquired factor VIII inhibitor responsive to high-dose gamma globulin.
    Green D; Kwaan HC
    Thromb Haemost; 1987 Dec; 58(4):1005-7. PubMed ID: 2451304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives on the use of factor IX complex concentrates in the treatment of bleeding in persons with acquired factor VIII inhibition.
    Lusher JM
    Am J Med; 1991 Nov; 91(5A):30S-34S. PubMed ID: 1746594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors.
    Abildgaard CF; Britton M; Harrison J
    J Pediatr; 1976 Feb; 88(2):200-5. PubMed ID: 1249680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience.
    Brettler DB; Forsberg AD; Levine PH; Aledort LM; Hilgartner MW; Kasper CK; Lusher JM; McMillan C; Roberts H
    Arch Intern Med; 1989 Jun; 149(6):1381-5. PubMed ID: 2499293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An inhibitor of antihemophilic factor (factor VIII) in an 18-month-old nonhemophilic child.
    Stein J; Ratnoff OD
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):346-50. PubMed ID: 8328652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
    Hayashi T; Niiya K; Sakuragawa N; Ichihara K; Yamazaki T; Watanabe A
    Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.
    Kelly P; Penner JA
    JAMA; 1976 Nov; 236(18):2061-4. PubMed ID: 989788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful induction of immune tolerance by continuous infusion of recombinant factor VIII in a haemophilia A patient with high-inhibitor titres.
    Tamura K; Kanazawa T; Suzuki M; Shioya A; Morikawa A
    Haemophilia; 2006 Jan; 12(1):100-2. PubMed ID: 16409184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors in haemophilia A: current management and open issues.
    Haya S; Moret A; Cid AR; Cortina V; Casaña P; Cabrera N; Aznar JA
    Haemophilia; 2007 Dec; 13 Suppl 5():52-60. PubMed ID: 18078398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individualised treatment of seven cases of acquired factor VIII inhibitors.
    Tien SL; Tan P; Ong YW; Loh TF
    Ann Acad Med Singap; 1991 Nov; 20(6):745-9. PubMed ID: 1803961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic factor VIII inhibitor autoantibody in a man presented after accident.
    Mansouritorghabeh H; Lak M; van Heerde WL
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):588-90. PubMed ID: 18550586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultracentrifugal analysis of factor VIII and von Willebrand factor in therapeutic preparations.
    Aronson DL; Chang P
    Vox Sang; 1995; 69(1):8-13. PubMed ID: 7483501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful immune tolerance treatment with monoclonal or recombinant factor VIII concentrates in high responding inhibitor patients.
    Rocino A; de Biasi R
    Vox Sang; 1999; 77 Suppl 1():65-9. PubMed ID: 10529692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elective cardiac operation in a patient with severe hemophilia and acquired factor VIII antibodies.
    Leggett PL; Doyle D; Smith WB; Culpepper W; Cooper S; Ochsner JL
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):556-60. PubMed ID: 6423912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of factor VIII inhibitors: evolution and current status.
    Bloom AL
    Haemostasis; 1992; 22(5):268-75. PubMed ID: 1478538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.